4D Molecular Therapeutics, Inc.
SEC Filing List
FDMT CIK: 0001650648
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 144 | Filing for proposed sale of securities u... | Goldman Sachs & Co. LLC /FA | 08/19/2026 | ||
| 4 | Statement of changes in beneficial owner... | Bizily Scott | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/17/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 08/17/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | 4d Molecular Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/13/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 08/13/2026 | ||
| 8-K | Current report filing | 4d Molecular Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/13/2026 | |
| 4 | Statement of changes in beneficial owner... | Kirn David | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/05/2026 | |
| 144 | Filing for proposed sale of securities u... | Goldman Sachs & Co. LLC /FA | 08/04/2026 | ||
| 4 | Statement of changes in beneficial owner... | Kirn David | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/04/2026 | |
| 144 | Filing for proposed sale of securities u... | Goldman Sachs & Co. LLC /FA | 08/03/2026 | ||
| No record found. | |||||
| Load More | |||||
